depression researchers

Researchers are examining whether participants' age may help explain why psychedelic studies reach different conclusions. Older adults may respond differently to psychedelic therapies than younger participants, which could account for variability across trials. The question matters as psychedelics move closer to regulated clinical use for depression and other mental health conditions.

Researchers report identifying a molecular switch triggered by stress that appears to drive depression, according to a report by Bioengineer.org. The finding could shed light on how chronic stress produces changes in the brain that lead to depressive symptoms, potentially opening new avenues for treatment. Details of the underlying study, including the research team, publication venue and evidence, were not provided in available coverage.